Radiation treatment monitoring with DCE-US in CWR22 prostate tumor xenografts.

DCE-US has been shown to detect vascular changes at a very early stage after radiotherapy, which is a great advantage since DCE-US is non-invasive, available at most hospitals, and is low in cost compared to other techniques used in clinical practice.